(Reuters) – Pfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the United States over cancer risks associated with its now-discontinued heartburn drug Zantac, the Financial Times reported on Thursday.
(Reporting by Utkarsh Shetti in Bengaluru; Editing by Nivedita Bhattacharjee)
